News|Articles|June 5, 2014

Bayer Extends CEO Contract

Bayer extends its CEO contract with Marijn Dekkers until 2016.

Bayer will extend Marijn Dekkers, PhD, contract as CEO for an additional two years, until the end of 2016.Werner Baumann, currently CFO, will become chief strategy and portfolio officer effective Oct. 1, 2014. Also effective Oct. 1, 2014, Johannes Dietsch, currently senior Bayer representative and CFO for Greater China based in Shanghai, will assume the position of CFO.

Source: Bayer

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Bayer Extends CEO Contract

Related Content

Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers

Regulatory Actions for June 2026

BioPhorum Unites 20 Organizations to Modernize Small Molecule Production

FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients

Roche Gets Priority Review for Enspryng; Announces Sequencing Platform

Trending on Pharmaceutical Technology

FDA Chooses 7 Companies for PreCheck Pilot

Documentation Reliability Across Contractors: A Quality Systems Approach

Lonza Increases HPAPI Production at Visp Facility

FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients

Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection